6-K
File 001-11960
ASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT
- Filing date
- 29 Sep 2026
- Reporting date
- 29 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
ASTRAZENECA PLC reports
- Company location
- Cambridge
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
ASTRAZENECA PLC has filed 2,047 SEC EDGAR filings since 13 Mar 1995
SEC filing history
Showing 1-25 of 1,000 matching filings.
Per page
25
Current page
1
6-K
File 001-11960
TRIXEO APPROVED IN EU FOR ASTHMA
- Filing date
- 23 Sep 2026
- Reporting date
- 23 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
KLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP
- Filing date
- 21 Sep 2026
- Reporting date
- 21 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC
- Filing date
- 21 Sep 2026
- Reporting date
- 21 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 18 Sep 2026
- Reporting date
- 18 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 15 Sep 2026
- Reporting date
- 15 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 15 Sep 2026
- Reporting date
- 15 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
UPDATE ON SERENA-4 PHASE III TRIAL
- Filing date
- 14 Sep 2026
- Reporting date
- 14 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
OWNERSHIP DOCUMENT
- Filing date
- 11 Sep 2026
- Reporting date
- 08 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
IMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG
- Filing date
- 08 Sep 2026
- Reporting date
- 08 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER
- Filing date
- 08 Sep 2026
- Reporting date
- 08 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ADMISSION OF FURTHER SECURITIES TO TRADING
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
TOTAL VOTING RIGHTS
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ADMISSION TO TRADING - EUR2.55 BILLION BOND OFFERING
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ENHERTU APPROVED IN EU FOR 1L HER2-POSITIVE MBC
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTORATE CHANGE
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ASTRAZENECA COMPLETES AGREEMENT FOR ZEGFROVY
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
TAGRISSO + ORPATHYS IMPROVED PFS IN 1L EGFRM LUNG
- Filing date
- 01 Sep 2026
- Reporting date
- 01 Sep 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
TEZSPIRE CROSSING TRIAL MET PRIMARY ENDPOINTS
- Filing date
- 27 Aug 2026
- Reporting date
- 27 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ASTRAZENECA PRICES A EUR2.55 BILLION BOND OFFERING
- Filing date
- 25 Aug 2026
- Reporting date
- 25 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 19 Aug 2026
- Reporting date
- 19 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ENHERTU IMPROVED PFS IN 1L HER2M LUNG CANCER
- Filing date
- 17 Aug 2026
- Reporting date
- 17 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
UPDATE ON EVOLVE-LUNG02 PHASE III TRIAL
- Filing date
- 17 Aug 2026
- Reporting date
- 17 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
TAGRISSO+ORPATHYS IMPROVED PFS & OS IN EGFRM LUNG
- Filing date
- 17 Aug 2026
- Reporting date
- 17 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
PRIMARY DOCUMENT
- Filing date
- 07 Aug 2026
- Reporting date
- 06 Aug 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing